632 related articles for article (PubMed ID: 19817543)
1. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
5. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
[TBL] [Abstract][Full Text] [Related]
6. Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.
Andaloussi-Saghir K; Oukabli M; El Marjany M; Sifat H; Hadadi K; Mansouri H
N Am J Med Sci; 2011 Nov; 3(11):527-30. PubMed ID: 22361502
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
8. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of temozolomide treatment in patients with high-grade glioma.
Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
[TBL] [Abstract][Full Text] [Related]
10. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
Dawar R; Fabiano AJ; Qiu J; Khushalani NI
Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
12. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital.
Chansriwong P; Sirisinha T
J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S68-73. PubMed ID: 21299082
[TBL] [Abstract][Full Text] [Related]
17. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH
Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]